04 - Neurosurgical / 04.07 - NEUROSTIMULATION THERAPIES FOR SEIZURE CONTROL / 04.07.01 - Vagal nerve stimulators

04.07.01.02 - Lead

3 devices · 1 sponsors

March 2027 window closes in 92 days

Median benefit

$3069.00

Range

$3069–3069

Comparator candidates

Code	Device · sponsor	Benefit	Tier 1 comparator?
SA175	VNS Therapy Lead Livanova Australia Pty Limited	$3069.00	eligible
SA187	VNS Therapy PerenniaFLEX Model 304.2 & 304.3 Livanova Australia Pty Limited	$3069.00	eligible
SA191	LivaNova PerenniaDURA Lead Model 303 for Vagus Nerve Stimulation Livanova Australia Pty Limited	$3069.00	eligible

3 device(s).

Tier pre-screener

Indicative only — pathway choice is the sponsor's responsibility.

TGA class of your device Well-established technology? Listing in this existing grouping? Interchangeable with a comparator here?

4-year benefit estimate

For the HPP utilisation section — arithmetic on your inputs.

Benefit $ Units/yr (low) Units/yr (high)

Year	Low	High
4-year total

Data: current Prescribed List · Calculations are based on published government data and figures you enter — a lookup and arithmetic tool, not regulatory or billing advice · Not an official government service.